Sign up to save your podcasts
Or
Share A Challenger to Interim PET in Lymphoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Challenger to Interim PET in Lymphoma
Dr. Bruce Cheson reports on recent data suggesting that measurement of metabolic tumor volume and total lesion glycolysis may be a better predictor of outcome in lymphoma than interim PET scanning.
View all episodes
By MedscapeDr. Bruce Cheson reports on recent data suggesting that measurement of metabolic tumor volume and total lesion glycolysis may be a better predictor of outcome in lymphoma than interim PET scanning.